US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Johnson & Johnson (NY:JNJ)

256.03 -2.63 (-1.02%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
JNJ will release its Q2 earnings on July 15, with analysts expecting earnings of $2.85 per share and revenue of $25.05 billion. Stock rose 3.6%. 
Via Benzinga
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway. ↗
Via Chartmill
News headline image
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly? ↗
Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors. 
Via The Motley Fool
News headline image
Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention. ↗
Politicians serve on committees that set healthcare policy, monitor government contracts, and shape regulatory frameworks. 
Via The Motley Fool
Topics Law Enforcement
How to Find Dividend Stocks That Won’t Blow Up, Featuring Johnson & Johnson (NYSE:JNJ) ↗
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
TechMediaBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Surpasses Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), Medtronic (NYSE: MDT) for Top Surgical Robotics Award
Via Investor Brand Network
News headline image
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How do their financials and risks stack up? 
Via The Motley Fool
News headline image
If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buy ↗
It can provide some stability during volatile times. 
Via The Motley Fool
Topics Economy
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
These 3 Dividend Stocks Could Boost Your Income This July ↗
Realty Income, Johnson & Johnson, and Chevron offer yields ranging from 2.2% to 5.1% in July 2026, supported by analyst buy ratings and institutional accumulation. 
Via MarketBeat
Topics Economy
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity 
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income ↗
All three ETFs complement each other well in a portfolio. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
This Vanguard ETF Is Built for a Market That's Finally Rotating Away From Big Tech ↗
As the megacap tech trade sputters, one attractive fund already owns what's leading instead -- and it's beating the market this year. 
Via The Motley Fool
Topics ETFs
Top dow jones movers in Monday's session ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Monday. ↗
Via Chartmill
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market. 
Via The Motley Fool
Topics Intellectual Property
News headline image
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000 ↗
Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot. 
Via The Motley Fool
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Why Johnson & Johnson Stock Popped on Friday ↗
Johnson & Johnson stock makes good drugs, but it's valuation isn't great. 
Via The Motley Fool
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow. 
Via The Motley Fool
News headline image
J&J CEO Now Sees 'Line of Sight' to Double-Digit Growth for His $100 Billion Company. Here's Why Investors Should Pay Attention. ↗
Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of big products suggest it still has growth appeal. 
Via The Motley Fool
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >